• 4070 Citations
  • 40 h-Index
20102020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Cristian Rodriguez-Aguayo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 4070 Citations
  • 40 h-Index
  • 97 Article
  • 9 Comment/debate
  • 4 Review article
  • 2 Chapter

Author Correction: Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression (Nature Communications, (2014), 5, 1, (5202), 10.1038/ncomms6202)

Rupaimoole, R., Wu, S. Y., Pradeep, S., Ivan, C., Pecot, C. V., Gharpure, K. M., Nagaraja, A. S., Armaiz-Pena, G. N., McGuire, M., Zand, B., Dalton, H. J., Filant, J., Miller, J. B., Lu, C., Sadaoui, N. C., Mangala, L. S., Taylor, M., van den Beucken, T., Koch, E., Rodriguez-Aguayo, C. & 9 others, Huang, L., Bar-Eli, M., Wouters, B. G., Radovich, M., Ivan, M., Calin, G. A., Zhang, W., Lopez-Berestein, G. & Sood, A. K., Dec 1 2020, In : Nature communications. 11, 1, 2867.

Research output: Contribution to journalComment/debate

Open Access
  • Blockade of cdk7 reverses endocrine therapy resistance in breast cancer

    Attia, Y. M., Shouman, S. A., Salama, S. A., Ivan, C., Elsayed, A. M., Amero, P., Rodriguez-Aguayo, C. & Lopez-Berestein, G., Apr 2 2020, In : International journal of molecular sciences. 21, 8, 2974.

    Research output: Contribution to journalArticle

    Open Access
  • Corrigendum to ‘Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer’ [EBioMedicine 38 (2018) 100–112](S2352396418304973)(10.1016/j.ebiom.2018.11.004)

    Kanlikilicer, P., Bayraktar, R., Denizli, M., Rashed, M. H., Ivan, C., Aslan, B., Mitra, R., Karagoz, K., Bayraktar, E., Zhang, X., Rodriguez-Aguayo, C., El-Arabey, A. A., Kahraman, N., Baydogan, S., Ozkayar, O., Gatza, M. L., Ozpolat, B., Calin, G. A., Sood, A. K. & Lopez-Berestein, G., Feb 2020, In : EBioMedicine. 52, 102630.

    Research output: Contribution to journalComment/debate

    Open Access
  • 1 Scopus citations

    NRG1/ERBB3 Pathway Activation Induces Acquired Resistance to XPO1 Inhibitors

    Miyake, T. M., Pradeep, S., Bayraktar, E., Stur, E., Handley, K. F., Wu, S., Rodriguez-Aguayo, C., Lee, J. S., Lopez-Berestein, G., Coleman, R. L. & Sood, A. K., Aug 1 2020, In : Molecular cancer therapeutics. 19, 8, p. 1727-1735 9 p.

    Research output: Contribution to journalArticle

  • Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer

    Lara, O. D., Bayraktar, E., Amero, P., Ma, S., Ivan, C., Hu, W., Wang, Y., Mangala, L. S., Dutta, P., Bhattacharya, P. K., Ashizawa, A. T., Lopez-Berestein, G., Rodriguez-Aguayo, C. & Sood, A. K., Jul 21 2020, In : Oncotarget. 11, 29, p. 2819-2833 15 p.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations